生物科技新聞

過濾

Reset filter
2023/9/24 新聞

Novotech 榮獲 2023 年細胞與基因治療 CRO 卓越獎

新加坡, Sept.

報告
2023/9/14 新聞

Novotech 发布胆囊癌临床试验全球综合情况报告

波士顿，2023 年 9 月 7 日-- 以亚太地区为中心、具有国际执行能力的专业生物技术 CRO

報告
2023/9/14 新聞

Novotech 發布鼻咽癌全球臨床試驗概況報告

波士頓, Sept.

報告
2023/7/12 新聞

Novotech 入圍 2023 年亞太細胞和基因療法 CRO 卓越獎決賽

新加坡, July 14, 2023 -- 以亞太區為中心，擁有全球營運能力的生物科技 CRO 領導者 Novotech，成為 2023

報告
2023/7/10 新聞

Novotech 將在 2023 年韓國生物製藥技術展上舉辦臨牀試驗成功因素技術研討會

韓國首爾, July 11, 2023 -- Novotech 是一間亞太地區領先且具有全球營運能力的生物科技合同研究組織 (CRO)，其將在 2023 年韓國生物製藥技術展 (BIOPLUS-

報告
2023/6/21 新聞

Novotech 榮獲 2023 年生物科技 CRO 領導獎

波士頓，2023 年 6 月 21 日-- 作為亞太地區頂尖生物科技 CRO 公司，具有全球營運能力的 Novotech 在「兼容性」(Compatibility) 類別中超越了生物科技客戶的期

報告
2023/5/29 新聞

Novotech 贊助 2023 年北美生物科技產業展 (BIO 2023) 的亞太峰會，並贊助 Endpoints 舉辦關於與中國建立生物科技合作的討論會

美國 - 麻薩諸塞州波士頓 - Novotech 是亞太地區領先的生物科技受託研究機構 (CRO)，為下列兩項活動提供贊助：

報告
2023/5/26 新聞

Novotech 贊助 2023 年 ASCO 年會：與世易醫健 (eChina Health) 聯合舉辦腫瘤峰會，並與 Endpoints 聯合召開加速藥物開發的專家小組討論會

美國伊利諾州芝加哥 - Novotech 是亞太地區領先的生物科技受託研究機構 (CRO)，為美國臨床腫瘤學會 (ASCO) 的兩項以腫瘤學為重點的專家活動提供

報告
2023/5/5 新聞

行業調查確定成功的生物技術臨床試驗策略

澳洲雪梨 - 以亞太地區為中心的領先生物技術受託研究機構 (CRO) Novotech 日前與 Citeline 合作，對全球生物技術專業人員進行一項調查，內容

報告
2023/4/13 新聞

Novotech 加入美國癌症研究協會 (AACR) 主辦、世易醫健 (eChinaHealth) 承辦的專家小組討論會，探討與中國癌症研究產業的合作經驗

以亞太地區為中心、並在生物科技業居於領先地位的受託研究機構 (CRO) Novotech，與腫瘤學界的權威人士共同參加美國癌症研究協會 (AACR) 主辦、世易醫健 (eChinaHealth)

報告
2023/3/31 新聞

GlobalData 發佈 FDA 生物技術批准途徑之監管指南和戰略報告

雪梨 - 以亞太地區為中心的頂尖生物技術 CRO Novotech 已委託 GlobalData 針對亞太、歐洲和美國生物技術而不斷發展的 FDA 批准流程提出

報告
2023/3/14 新聞

Novotech 發布多特異性單株抗體全球臨床試驗概況報告

新加坡 - 以亞太地區為中心的頂尖生物技術 CRO Novotech 發佈了一份關於全球多特異性單株抗體 (Mabs) 臨床試驗現狀的新報告，包括對亞太地區、歐

報告
2023/3/7 新聞

BIO Europe 的 Novotech 團隊分享擴大全球運營的好處

新加坡 - 以亞太地區為中心的領先生物技術 CRO Novotech 將參加 BIO Europe（2023 年 3 月 20 日至 22 日），與臨床階段的生

報告
2023/3/3 新聞

專家分享對不斷發展的全球疫苗格局的見解，包括 mRNA 趨勢

Novotech 是領先的以亞太地區為中心的生物技術 CRO，在疫苗試驗方面擁有豐富的經驗，正在召開一次專家小組網絡研討會，討論疫苗開發不斷發展的格局。

報告
2023/2/10 新聞

Novotech 全球報告：亞太地區穩健的 1 期試驗增長

以亞太地區為中心的領先生物技術 CRO Novotech 發布了一份關於 Phase 1 試驗活動的新全球報告，包括快速增長區域和治療領域的當前指標。

報告
2023/2/2 新聞

亞太地區細胞與基因研究：Novotech 的增長速度比 世界其它地區快 50%

Novotech 是亞太地區領先的生物技術專家 CRO 和亞太地區細胞與基因治療臨床試驗卓越獎的獲得者，該公司表示該地區細胞與基因治療試驗的數量增長速度比世界其它地區快 50%。

報告
2023/1/10 新聞

Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…

Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In

報告
2023/1/10 新聞

Novotech Acquires European CRO – Strengthens Global Operations

Novotech announced today the acquisition of EastHORN, a European CRO with clinical, medical and r

報告
2023/1/5 新聞

Novotech Team Joins BIO Partnering at JPM 2023

Novotech, the Asia Pacific centered biotech specialist CRO, will attend JPM 2023 and experts from

報告
2022/12/21 新聞

Novotech Sponsors “The Next Big Thing in Cancer Care” Webinar - CAR-T, Precision Oncology, AI and…

Novotech, the Asia Pacific centered biotech specialist CRO, presents “The Next Big Thing in Cance

報告
2022/12/19 新聞

Novotech is Gold Sponsor at Biotech Showcase 2023

Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech

報告
2022/12/16 新聞

CEO End of year announcement December 2022

報告
2022/12/15 新聞

Data Shows 50% of New Trials Have Sites in Asia Pacific

Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publ

報告
2022/12/6 新聞

Novotech 榮獲 2022 年亞太地區 CRO 臨床試驗最佳實踐獎

Novotech 是亞太地區領先的生物技術專家合同研究機構，因其在亞太地區合同研究組織行業的最佳實踐而榮獲 2022 年 Frost & Sullivan 年度公司獎。

報告
2022/11/22 新聞

Oncoshot and Novotech Partner to Offer Cancer Data Insights

SINGAPORE, October 2022 /PRNewswire/ -- Oncoshot and internationally recognised contract research

報告
2022/11/14 新聞

Novotech 主持關於如何建立和資助東西方 MRCT 戰略的 BioCentury 峰會研討會

Novotech 是亞太地區領先的生物技術專家合同研究機構，正在讚助 2022 年 BioCentury-BayHelix 東西方峰會，Novotech 的首席商務官 Barry Murphy

報告
2022/10/26 新聞

中國的臨床研究機會和美國食品藥品監督管理局批准的途徑 - 白皮書

Novotech、亞太地區領先的生物技術專家合同研究機構和GlobalData發布了最新的中國生物技術前景分析，並就美國 FDA 批准在中國開展研究的生物技術的途徑提供專家指導。

報告
2022/10/20 新聞

生物技術領域網絡研討會：市場趨勢、優先事項、預測和 FDA 批准途徑

Novotech 是亞太地區領先的生物技術專家合同研究機構和 Endpoints News 為生物技術公司舉辦的網絡研討會，涵蓋了亞太地區的臨床研究機會和獲得 FDA 批准的監管途徑。

報告
2022/10/12 新聞

Novotech 印度區被全球工作標準權威機構評選為「2022 年女性最佳職場」

亞太地區領先的生物科技專業受託研究機構 Novotech 再次獲得領先的最佳工作場所機構 「卓越職場研究機構」 (Great Place to Work Institute)

報告
2022/10/7 新聞

Featured in the endpoints news- the factors driving a rapid evolution of gene & cell therapy and…

APAC is the fast growing region globally for cell & gene therapy trials representing

報告
2022/10/7 新聞

Novotech 當選 Scrip 獎最佳入圍者 全方位服務的臨床研究機構

澳大利亞悉尼 - Novotech 是亞太地區領先的生物技術臨床研究機構，加入了享有盛譽的全球臨床研究機構團體，入圍 Scrip 獎最佳全方位服務 CRO。

報告
2022/9/15 新聞

Novotech 在第六屆細胞與基因治療世界亞洲會議上榮獲 2022 年細胞與基因卓越獎

Novotech 是亞太地區領先的生物技術臨床研究機構，在 2022 年第 6 屆亞洲細胞與基因治療世界大會上獲得了細胞與基因治療臨床試驗獎。

報告
2022/9/5 新聞

NOVOTECH 參加 2022 年歐洲腫瘤學學會大會 (ESMO CONGRESS) — 新資料顯示亞太地區的腫瘤試驗成長率達 100%

在 #409 號展位與團隊會面 

報告
2022/9/2 新聞

根據 GlobalData 的新報告，亞太地區吸引 50% 的全球臨床試驗

Novotech 是亞太地區首屈一指的生物科技專業 CRO 公司，已在一份標題為 《亞太地區的臨床試驗進展》 的報告中，公開發布了新的市場資料。

報告
2022/7/25 新聞

Novotech 的彈性工作政策入圍最佳工作場所彈性計劃「2022 年卓越獎」

Novotech 是亞太地區領先的生物技術專業受託研究機構 (CRO)，近期進駐美國拓展公司服務，因其創新的工作場所彈性方法而獲得認可。 

報告
2022/7/21 新聞

Novotech 擴大與 Medidata 的合作夥伴關係，繼續推展臨床研究服務

亞太地區領先的生物科技專業 CRO Novotech 與 Medidata 延續合作夥伴關係，將進一步對亞太地區和美國的 Novotech 客戶擴大服務範圍

報告
2022/7/19 新聞

Novotech 和 Endpoints 展示「中國的細胞與基因治療進展：通用嵌合抗原受體 T 細胞 (Universal CAR-T) 的案例」

雪梨 - Novotech 是亞太地區領先的生物科技專業 CRO，美國地區也有拓展服務。

報告
2022/7/14 新聞

Novotech 的亞太地區和美國領導 團隊參加 2022 生物科技展會

聖地牙哥 - 美國 - Novotech 是亞太地區領先的生物科技專業 CRO，最近將其服務擴展到美國，將邀請來自亞太地區和美國的重要高階主管參加 2022 年

報告
2022/7/13 新聞

Novotech 客戶 SK bioscience 在韓國獲得 SKYCovione™ COVID-19 疫苗核准

韓國首爾 - Novotech 是亞太地區領先的生物科技專業受託研究機構 (CRO)，近期入駐美國拓展其服務，祝賀其客戶 SK bioscience 最近獲得

報告
2022/6/30 新聞

Novotech 在 2022 年韓國生物製程卓越獎中獲得「2022 年最佳生物製劑 CRO 獎」

南韓首爾 - Novotech 是亞太地區領先的生物科技專業受託研究機構 (CRO)，近期已將其服務拓展至美國。

報告
2022/6/22 新聞

Novotech 因超出客戶期望而獲得 CRO 領導獎

芝加哥 - 美國 - Novotech 是亞太地區領先的生物科技專業 CRO，最近將其服務擴展到美國，在 2022 年藥物資訊協會 (DIA 2022) 上因超

報告
2022/6/6 新聞

Novotech 助力 Endpoints ASCO 2022 年專家小組加速中國腫瘤臨床試驗進程

雪梨 - Novotech 是亞太地區首屈一指的生物科技專業 CRO，近期進駐美國拓展其服務範圍，助力 Endpoints ASCO 2022 年專家小組，「加速中國和美國臨床試

報告
2022/6/2 新聞

Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組

澳大利亞悉尼 - Novotech 是亞太地區領先的生物技術專家 CRO，最近將其服務擴展到美國，在 2022 年 ASCO 前中國峰會上贊助了專家小組，匯集了

報告
2022/5/26 新聞

Novotech收購美國合同研究組織(CRO)，拓展全球專業領域

新加坡和南卡羅來納州查爾斯頓 - 亞太地區領先的生物技術專業企業Novotech已收購美國合同研究組織NCGS。這是其針對全球客戶群的服務擴展計劃的一部分。

報告
2022/3/18 新聞

Novotech 再次被認證為性別平等優良僱主

雪梨 - 澳洲 – Novotech 是亞太地區領先的生技專業 CRO，已再次被「職場性別平等機構 (WGEA)」認證為「WGEA 性別平等優良雇主 (EOCG

報告
2022/3/8 新聞

國際婦女節

報告
2022/3/1 新聞

韓國 Novotech 榮登卓越職場研究機構 (Great Place to Work Institute)「前 100 大最佳職場」。

Novotech 是亞太地區領先的生技專業 CRO，另外也獲得了總共五個類別的獎項，包括由「卓越職場®研究機構」所頒發的「前 100 大最佳職場」獎。

報告
2022/2/7 新聞

Novotech Recognized as Top 10 CRO in CenterWatch Site Relationship Benchmarking Report

Sydney - Novotech, the leading Asia Pacific biotech specialist CRO, has been rec

報告
2022/1/25 新聞

Prospection and Novotech Partner To Accelerate Clinical Trials with Real World Evidence

Global healthcare data technology company, Prospection

報告
2021/12/17 新聞

西方國家的生物科技公司加快中國藥物開發之四大關鍵策略

作為蓬勃發展的臨床試驗市場，中國為臨床創新提供了大量機會。

報告
2021/12/14 新聞

CEO End of year announcement December 2021

Dear Customers, Partners, and Colleagues,  As the year draws to a close, I would like t

報告
2021/11/29 新聞

Congratulations to the Novotech Seoul Korea team

Congratulations to the Novotech Seoul, Korea team on the execution of a new partnership MOU for c

報告
2021/11/9 新聞

Novotech Platinum Sponsor at ChinaTrials13 Summit Shanghai 2021

Sydney - Novotech, a leading biotech specialist CRO in the Asia-Pacific region,

報告
2021/10/22 新聞

韓國 Novotech 被世界權威的工作場所文化機構認證為最佳工作場所

首爾 – 韓國 – Novotech 是亞太地區的生技專業 CRO，已再次被領先的工作場所文化機構 卓越職場®研究機構 (The Great Place to Work® Institute)

報告
2021/10/18 新聞

Novotech 支援 GoGive1 疫苗接種活動，作為全公司 COVID 安全工作場所政策之一部分

香港 - Novotech 是亞太地區領先的生技專業 CRO，在全球各地共有超過 2,000 名員工，並已加入 GoGive1 疫苗接種活動，對於每位已完全接種疫苗的團隊成員，該活動將捐贈 1

報告
2021/10/8 新聞

Clinical Leader Announces Novotech a 2021 CRO Leadership Award Winner

Clinical Leader and Life Science Leader, working with Industry Standard Researc

報告
2021/10/7 新聞

Novotech and ObvioHealth are finalists for the Clinical Partnership of the Year Citeline Award 2021

Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific regio

報告
2021/9/24 新聞

區域臨床試驗專員 (CRA) 長

臨床研究職涯的下一步

報告
2021/9/24 新聞

臨床資料管理

您可曾好奇過臨床資料管理的職涯會是什麼樣子？

報告
2021/9/20 新聞

Novotech Showcases Asia-Pacific Success as a Rare Diseases Clinical Trial Hub

Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific regio

報告
2021/9/7 新聞

Novotech named as one the Best Companies to Work for in Asia 2021

Taipei, 7 September 2021 

報告
2021/8/31 新聞

Novotech 執行長 John Moller 簽署 #IStandForRespect 宣言，加入超過 220 位執行長的行列

媒體發佈 2021 年 8 月 27 日

報告
2021/8/3 新聞

Novotech Awarded 2021 Frost & Sullivan Asia-Pacific CRO Company of the Year for Fifth Consecutive…

Novotech Health Holdings Pte. Ltd.

報告
2021/7/19 新聞

Novotech 加入去中心化試驗和研究聯盟 (Dtra) 以民主化和加速臨床試驗

香港—2021 年 7 月 20 日—Novotech Health Holdings Pte. Ltd.

報告
2021/7/5 新聞

Novotech 擴展虛擬臨床試驗能力

紐約—2021 年 7 月 1 日—全球虛擬研究機構 (VRO) ObvioHealth 宣布已在最新一輪融資中，集資了 3100 萬美元。

報告
2021/6/10 新聞

Novotech 連續第二年獲全球工作場 所文化機構認證肯定為最 佳工作場所

澳洲雪梨 – Novotech

報告
2021/4/1 新聞

Starting Your Clinical Journey With The End In Mind – The Value Of A Drug Development Plan

Establishing an intelligent clinical development program pathway from the start is vital for clar

報告
2021/2/11 新聞

Celebrating International Day for Women and Girls in Science 2021

Thursday 11 February 2021

報告
2021/2/1 新聞

Novotech Health Holdings Appoints Andy Liu as Head of China

SHANGHAI and SYDNEY, Jan.

報告
2021/1/12 新聞

Novotech South Korea Celebrates 100th Employee as Biotechs Turn to the Asia-Pacific for Study…

A leading Asia-Pacific biotech specialist CRO Novotech celebrates its 100th employee appointment

報告
2020/12/29 新聞

Novotech Health Holdings Appoints Zidong Zhang as CFO

SHANGHAI and SYDNEY, 29 December 2020 – Novotech Health Holdings (“Novotech Hold

報告
2020/12/16 新聞

An end of year message from Novotech CEO John Moller

Dear customers, partners and colleagues,  I want to start by acknowledging how difficul

報告
2020/12/8 新聞

Novotech Health Holdings Announces Appointment of Anand Tharmaratnam as Chairman

SHANGHAI and SYDNEY, 8 December 2020 – Novotech Health Holdings (“Novotech Holdi

報告
2020/10/12 新聞

Novotech and PPC Group Announce Merger to Form Novotech Health Holdings

Combined company will create largest specialist biotech CRO platform in Asia to meet the rapi

報告
2020/9/21 新聞

Novotech Finalist in Pharma Intelligence Citeline Awards 2020

Sydney, Australia – Novotech, the largest biotech specialist CRO in the Asia-Pac

報告
2020/9/8 新聞

Novotech CRO 根據南韓食品醫藥品安全處 (MFDS) 資料為生物技術 IND 核可的 CRO 前 3 名

澳洲雪梨 – Novotech 是亞太地區規模最大的生物技術專業委託研究機構 (CRO)，根據南韓食品醫藥品安全處 (MFDS) 資料為生物技術 IND 核可

報告
2020/8/26 新聞

Novotech the Asia-Pacific CRO Leader – Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of…

Sydney - Australia – Novotech, the largest biotech specialist CRO in the Asia-Pa

報告
2020/7/31 新聞

Novotech 獲全球工作場所文化機構認證肯定為「2020 最佳工作場所」

澳洲雪梨 – Novotech 是亞太地區規模最大的生物技術專業委託研究機構 (CRO)，日前由業界領先工作場所文化機構 The Great Place to

報告
2020/7/27 新聞

Novotech Partners with South Korea’s 800,000-patient Kyung Hee University Hospital at Gangdong for…

The leading Asia-Pacific biotech

報告
2020/7/23 新聞

The Strategic Opportunity: ‘Running First-in-human and Vaccine Studies in Australia’ - Novotech…

The leading Asia-Pacific biotech

報告
2020/6/15 新聞

Novotech Partners with South Korea’s 1,300-bed Pusan National University Hospital

The leading Asia-Pacific biotech

報告
2020/5/22 新聞

最新研究指出亞太地區臨床試驗單位的腫瘤試驗有高度持續性

根據癌症研究所 (Cancer Research Institute) 所做的最新研究結果指出，COVID-19 疫情對於亞洲以外其他地區的腫瘤臨床研究試驗單位影響較為嚴重，例如北美與歐洲地區。

報告
2020/5/11 新聞

Sponsors Select Novotech for CRO Leadership Award

The leading Asia-Pacific biotech

報告
2020/4/29 新聞

Novotech Selected as CRO for Karyopharm’s COVID-19 Clinical Study

The Asia-Pacif

報告
2020/4/24 新聞

Biotechnology Companies Turning to Asia-Pacific for Clinical Trials During North America Slowdown.

Biotechnology sponsors are attracted to the region because sites ha

報告
2020/4/22 新聞

Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes

The Asia-Pacific’s largest specialist biotech CRO Novotech said many coun

報告
2020/4/9 新聞

Novotech selected for new COVID-19 Clinical Trial in Asia-Pacific

Novotech has been engag

報告
2020/4/6 新聞

Novotech Data Shows majority of Australian sites are open for clinical trial activity

Sydney, Australia - Asia-Pacific’s largest specialist biotech CRO Novotech said

報告
2020/3/26 新聞

Managing the Covid-19 outbreak, lessons learnt from South Korea

Following the outbreak of Covid-19 in China in early 2020, later declared as a pandemic by the WH

報告
2020/3/21 新聞

Novotech Tapped for Two Informa Pharma Intelligence Citeline Awards for Excellence in Asia-Pacific…

Sydney, Australia - Asia-Pacific’s largest specialist biotech CRO Novotech has b

報告
2020/3/6 新聞

Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea

Seoul, South Korea - Asia-Pacific’s largest specialist biotech CRO Novotech has

報告
2020/2/25 新聞

Novotech 榮獲工作場所性別平等獎

澳洲雪梨– Novotech 是亞太地區規模最大的生物技術專業委託研究機構 (CRO)，日前已獲工作場所性別平等機構 (Workplace Gender Equ

報告
2020/2/20 新聞

Novotech Partners with National Taiwan University Hospital (NTUH) to Support Biotech Clinical…

Taipei, Taiwan – Asia-Pacific specialist CRO Novotech announced today that leadi

報告
2020/2/3 新聞

Novotech Wins Australian-Korean Business Excellence Award 2020

Seoul, South Korea - Asia-Pacific specialist CRO Novotech has w

報告
2020/1/13 新聞

Asia-Pacific has record year for clinical trials according to Novotech

San Francisco, CA – Novotech the largest biotech CRO in the Asia-Pacific said th

報告
2020/1/6 新聞

Immuno-Oncology clinical trial landscape in Asia-Pacific

A growing number of biotechnology companies are looking at Asia and Australia to run their 

報告
2019/12/10 新聞

Novotech CRO sees changing landscape in Hemato-Oncology at ASH 2019

Novotech, the Asia-Pacific CRO, attends the American Society of Hematology conference in Orla

報告
2019/12/4 新聞

Novotech and PPC Group Announce Strategic Partnership

Partnership Creates Region’s Largest Biotech CRO Platform to Meet Demand for Clinical Trials

報告
2019/12/4 新聞

Novotech and PPC Group Announce Strategic Partnership

Partnership Creates Region’s Largest Biotech CRO Platform to Meet Demand for Clinical Trials

報告
2019/11/22 新聞

Novotech’s Clinical Network Services wins GENE Awards for Industry excellence in biotech drug…

Clinical Network Services, a subsidiary of Novotech, the Asia-Pacific CRO, was awarded a prestigi

報告
2019/11/20 新聞

Novotech discusses biotechnology CRO services at leadership meeting in Malaysia

Novotech is a full service CRO, offering CRO services across all the Asia-Pacific region with ope

報告
2019/11/15 新聞

Asia-Pacific shows higher patient recruitment rates for Oncology clinical trials

Biotechnology companies are facing tremendous challenges around patient recruitment, lengthy time

報告
2019/11/13 新聞

Ovarian cancer landscape in the Asia-Pacific region

We are seeing a growing amount of 

報告
2019/11/7 新聞

Novotech discusses biotech clinical development plans in Asia and Australia at OCT conference in…

We’re in Boston and we are seeing tremendous interest from 

報告
2019/10/22 新聞

Novotech sees increased interest from US biotechs in Asia-pacific at OCT Southern California in La…

Novotech is focused on serving the biotech sector in the Asia Pacific region, we work with the mo

報告
2019/10/2 新聞

Novotech CRO Finalist in International Health Awards 2019

Sydney, Australia - Asia-Pacific specialist CRO Novotech has we

報告
2019/10/1 新聞

Novotech 推動彈性工作而成為 CRO 服務產業中的優良工作場所

Novotech CRO，業界領先的亞太地區 CRO，持續拓展為生物技術產業提供高品質臨床試驗 Novotech 成立多年，奠基於堅持不妥協的誠信價值、開放合作參與、對於效能

報告
2019/9/25 新聞

Orphan Drugs - Clinical trial landscape in Asia-Pacific

We have observed an unprecedented global effort in the clinical development of Orphan drugs

報告
2019/9/17 新聞

Novotech CRO at 2019 KoNECT-MOHW-MFDS International Conference, Seoul, South Korea

Seoul, South Korea – Award-winning Asia-Pacific specialist CRO Novotechwill atte

報告
2019/9/16 新聞

Novotech CRO presents benefits of working with the leading Asia-Pacific CRO in Beijing and…

Beijing/Shanghai, China – Award-winning Asia-Pacific specialist CRO Novotech is

報告
2019/9/12 新聞

Novotech CRO says South Korea’s Five-Year Plan for the Advancement of Clinical Trials will further…

Asia-Pacific specialist CRO Novotech has welcomed the South Korean C

報告
2019/7/9 新聞

Novotech CRO partners with the Skin Research Institute of Singapore (SRIS) for skin disorders…

Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has furt

報告
2019/5/23 新聞

Novotech launches new site management organisation (SMO) business in South Korea

19 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO Novotech announced

報告
2019/5/17 新聞

Trials In Focus

Trials In Focus August 25, 2010

報告
2019/5/8 新聞

Novotech Update: Novotech presents to Chinese biotechs on 3 key benefits of early stage clinical…

Novotech presented to a number of biotechnology companies based at China’s 

報告
2019/5/6 新聞

Asian Century and clinical trials: Issues for consideration by biotechnology companies

Together with already large pharmaceutical markets such as Japan, it is not difficult to see why

報告
2019/4/16 新聞

Novotech Update: EMA releases addendum to ICH Guidelines, highlighting importance of considering…

The European Medicines Agency (EMA) recently released an addendum regarding International Confere

報告
2019/4/8 新聞

BioSpectrum India: Novotech remains very optimistic about the future of clinical trials in India

Many of these challenges have now been resolved, but the reality is that sponsors have been much

報告
2019/3/27 新聞

Trials In Focus

April 19, 2010 Novotech partners with Citeline

報告
2019/3/26 新聞

New Study of Investigational Alzheimer’s Disease Treatment Enrolling Patients in Australia

August 31, 2009

報告
2019/2/25 新聞

Novotech signs MOU with South Korea’s SCI-Consortium and Severance Hospital

31 July 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO No

報告
2019/2/19 新聞

ARCS 2017: Australia plays a key role in bringing clinical research to Asia, says Novotech

During a panel discussion at this year’s ARCS 2017, Novotech CEO Dr John Moller discussed Austral

報告
2019/1/29 新聞

Novotech Update: South Korea to cover standard of care for patients participating in clinical trials

In a recent update, South Korea’s National Health Insurance Program outlined plans to also cover

報告
2019/1/4 新聞

Accelerating Clinical Trials in Asia 2017: Changes to Asia’s regulatory environment increasing its…

Presenting at this year’s Accelerating Clinical Trials in Asia 2017, Novotech CRO Executive Direc

報告
2018/12/17 新聞

Novotech Update: Novotech and Deloitte brief biotech companies on benefits of accessing Australia’s…

10 January 2017; San Francisco, California, United States: At a private event du

報告
2018/12/10 新聞

Outsourcing Clinical Trial South California 2017: Regulatory change is increasing Asia’s…

At this year’s Outsourcing Clinical Trial South California 2017, Novotech Director Mr Barry Murph

報告
2018/11/27 新聞

NZACRes 2017: Novotech outlines opportunities for New Zealand to increase clinical trial…

<p>Presenting at NZACRes 2017, Novotech warned New Zealand must continue to invest in areas

報告
2018/10/15 新聞

CenterWatch

Novotech Becomes Medidata Solutions’ Partner

報告
2018/8/24 新聞

Novotech in new research collaboration: Biotechnology News

LEADING Australian contract clinical research company Novotech, Marine Biotechnology Australia an

報告
2018/8/8 新聞

Alchemia Recruits Full Patient Quota to Pivotal Phase III HAIrinotecan Trial in Metastatic…

Brisbane, Australia 4th Feb 2013: Brisbane-based drug discovery and development company Alchemia

報告
2018/8/1 新聞

Novotech wins 2017 Asia Pacific Biotech CRO award

Leading Asia Pacific CRO Novotech has won Asia Pacific Biotech CRO Company of The Year a

報告
2018/6/7 新聞

Sponsors Recommend Novotech for CRO Leadership Award

Asia-Pacific specialist CRO Novotech has been awarded the “Exceeded Customer Expectations” Award

報告
2018/6/1 新聞

Novotech and CNS deal expands CRO services for biopharma clients across Asia-Pacific

Novotech the largest Asia-Pacific-based CRO has acquired Australasian specialist CRO Clinical Net

報告
2018/5/1 新聞

Australia and Asia Pacific offer international biotech industry a wealth of clinical trial and…

Australia and the Asia Pacific are fast becoming the destination of choice for the over US$140 bi

報告
2018/4/20 新聞

Pharma Tech Outlook Magazine features Novotech in the top 10 CROs of the year

See Top 10 CRO article here

報告
2018/1/10 新聞

Outsourcing Pharma

Outsourcing Pharma 2nd June 2010

報告
2018/1/8 新聞

Novotech CRO Expands China Team as Biotech Demand for Clinical Trials Increases up to 79%

Originally published on 

報告
2017/12/11 新聞

Novotech Update: Asia’s international clinical trial profile will continue to increase in 2018,…

Presenting at this year’s Outsourcing Clinical Trials East Asia 2017 in Seoul, Novotech CRO Chief

報告
2017/12/11 新聞

TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence:…

TheraVida Initiates Phase 2 Trial of T

報告
2017/12/11 新聞

Novotech 與 Medidata 合作加速亞太區的臨床研究發現

首屈一指的亞太 CRO 和 Medidata 合作，以實現更智能、更快速的藥物開發

報告
2017/11/30 新聞

Why South Korea Is The Hottest Growth Spot For Clinical Trials

By Ed Miseta, Chief Editor, Clinical Leader – Originally published in Life Science Leader mag

報告
2017/11/3 新聞

World Pharma Today: Increasing clinical trial competition within Asia to benefit sponsors says…

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial

報告
2017/11/3 新聞

BioSpectrum Asia interviews Dr Yooni Kim on how she is growing the next generation of female…

報告
2017/10/23 新聞

Novotech Update: China implements 5 key changes to accelerate clinical trial and drug approval…

With patients in China having to wait a minimum of six years to access medications already approv

報告
2017/10/23 新聞

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

NOVOTECH CRO EXPANDS ASIA REGION SERVICES WITH NEW CHINA OFFICE IN SHANGHAI

報告
2017/10/18 新聞

Scrip Clinical Research News

June 2, 2010

報告
2017/10/16 新聞

The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in…

The Road Less Travelled – Navigation through the do’s and don’ts of running Oncology studies in A

報告
2017/10/5 新聞

Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO

The announcement was made at the ASCO Annual Meeting (May 31 - June 4, 2019  McCormick Place, Chi

報告
2017/10/3 新聞

Novotech CRO announces several key Hospital Partnerships in India and Thailand at OCT West Coast…

Asia-Pacific specialist CRO Novotech announced at OCT West 2019 a new powerful clinical partnersh

報告
2017/9/29 新聞

Webinar - Navigating Oncology Trials in Asia: How a Regional CRO can Deliver on a Global Project

Almost half of these occur in Asia with almost one quarter of the global burden in China.

報告
2017/9/20 新聞

Novotech announces transition of CEO role

“John brings tremendous leadership to Novotech, and a proven track record of success.

報告
2017/8/30 新聞

Novotech Update: Three clinical trial and regulatory updates you need to know for your next…

FDA agrees to IRB Waivers for Minimal Risk Studies 

報告
2017/8/30 新聞

Novotech CRO partners with the Skin Research Institute of Singapore (SRIS) for skin disorders…

Novotech now has over 20 significant Partnerships with some of the leading medical institutions in the region. The Partnership Program is strategically designed to bring unparalleled access to quality investigators, KOLs, and up to 4 million patients for its international biotech clients.

報告
2017/8/24 新聞

Novotech signs MOU with South Korea’s leading medical center, the Asan Medical Center

15 April 2017, Sydney, Australia and Seoul, Korea: Asia Pacific specialist CRO N

報告
2017/8/20 新聞

Novotech CRO 獲得 《Insights Care》 雜誌評選為亞太區前 10 大公司

《Insights Care》 雜誌研究團隊在 2019 年 5 月的封面故事「醫療保健業蓬勃發展的 10 家公司」中，特別報導了 Novotech CRO。

報告
2017/8/18 新聞

Webinar - Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors

However, as attractive as Asia may be, navigating the maze of trial logistics, local regulations

報告
2017/8/10 新聞

Pharmaceutical Business Review

PBR Staff

報告
2017/7/31 新聞

Novotech CRO Says Australia is Gateway to Asia Clinical Research, at Industry Event in Seoul

Asia-Pacific specialist CRO Novotech presented Australia's R&D Refund and Simplified Regulato

報告
2017/7/24 新聞

Novotech - A Catalyst for Growth and a Better Tomorrow

The cost of research for new drugs has almost tripled over the last 25 years and new models are e

報告
2017/7/24 新聞

Novotech and CNS Awarded Top Asia-Pacific CRO

This is the second year that Novotech, the largest Asia-Pacific-based CRO, has been selected as a

報告
2017/7/19 新聞

World Pharma Today: Increasing clinical trial competition within Asia to benefit sponsors says…

In an article drafted for World Pharma Today, Novotech explains on how increasing clinical trial

報告
2017/6/29 新聞

Novotech Partners with Asian Eye Institute for Accelerated Ophthalmic Drug and Devices Clinical…

<p>Asia-Pacific specialist CRO Novotech announced today it has partnered with the Asian Eye

報告
2017/6/19 新聞

Novotech Signs MOU with Clinical Research Malaysia

Novotech Malaysia has signed a Memorandum of Understanding with Clinical Research Malaysia (CRM)

報告
2017/6/13 新聞

Novotech CRO and Clinical Network Services (CNS) Announced as Finalists in 2019 Clinical & Research…

BOSTON – February, 25 – Novotech CRO and subsidiary Clinical Network Services (CNS) have been nam

報告
2017/4/15 新聞

Novotech CRO Awarded Frost & Sullivan Leading Biotech CRO in the Asia-Pacific

Asia-Pacific specialist CRO Novotech has been awarded the top Asia-Pacific CRO by Frost & Sul

報告
2017/1/27 新聞

Novotech CRO Presents Australia and Asia-Pacific Clinical Trial Trends and Latest Tax Breaks for…

Asia-Pacific specialist CRO Novotech has been invited to share the advantages of

報告
2017/1/27 新聞

Novotech CRO Launches Largest Oracle Trial Management and Monitoring Cloud Service Implementation…

Asia-Pacific specialist CRO Novotech announced as part of its ongoing IT infrastructure investmen

報告
2017/1/16 新聞

Novotech embarks on a new strategic partnership with Citeline, designed to accelerate patient…

15 April 2010

報告
2016/12/30 新聞

The Australian Government recently announced a new commitment of $100m to support rural, regional,…

Novotech 執行長 John Moller 醫師在評論這篇新聞時，談道：「我們很開心得知最近澳洲政府宣布，要幫助鄉村地區患有癌症和罕見疾病的澳洲人獲得新的治療方法。

報告
2016/12/20 新聞

Novotech Signs MOU with China Medical University Hospital in Taiwan to Offer Enhanced Services for…

Asia-Pacific specialist CRO Novotech announced today it has signed a Memorandum of Understanding

報告
2016/12/20 新聞

Novotech Signs MOU with King Chulalongkorn Memorial Hospital, Srinagarind Hospital and…

Novotech has partnered with several major sites in Thailand to facilitate high-quality and rapid

報告
2016/12/2 新聞

Novotech signs central lab services agreement with Sonic Clinical Trials

19 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced

報告
2016/11/2 新聞

Novotech CRO strengthens South Korean clinical capabilities by partnering with major hospitals

Novotech, the award-winning Asia-Pacific CRO, with 23 years of experience in the region, has furt

報告
2016/11/2 新聞

Trials In Focus

Trials In Focus June 21, 2010

報告
2016/9/27 新聞

Considerations for Asia Pacific clinical trials

The acceptability of data worldwide, a keen and well-qualified investigator community and sheer n

報告
2016/8/27 新聞

Novotech & Deloitte brief biotech companies on benefits of accessing Australia’s R&D scheme

Speaking at the event, Deloitte R&D Tax Incentives Account Director Megan O’Connor spoke on h

報告
2016/8/26 新聞

Novotech Update: India streamlines clinical trial approval process and reduces regulatory timelines

Minuted in June 2017, the Drug Controller General of India (DCGI) and Secretary of Health and Fam

報告
2016/6/27 新聞

CentreWatch Weekly covers Novotech's rapid growth in South Korea

July has been a big month for Novotech in South Korea.

報告
2016/2/11 新聞

Novotech Update: Novotech and Deloitte Launch U.S. Biotech Briefings about 60% Savings for Early…

Sydney, Australia – October 27, 2016: In an industry first Novotech and Deloitte

報告
2016/1/8 新聞

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

Novotech initiates cancer trials in Australia and New Zealand for Oncomed Pharmaceuticals

報告
2015/12/15 新聞

Novotech receives ISO 9001:2015 certification

29 June 2017, Sydney, Australia: Asia Pacific specialist CRO Novotech announced today it has rece

報告
2015/11/27 新聞

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed

Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed

報告
2015/3/2 新聞

Novotech Update: Malaysian government invests in its early stage research industry and launches new…

Malaysia’s clinical trials industry body Clinical Research Malaysia (CRM) has launched the countr

報告
2015/1/19 新聞

CIO

  Novotech Selects Oracle’s Siebel Clinical Trial Management

報告
2014/12/19 新聞

Australian CRO Novotech announces expanded Asia reach into Hong Kong and Philippines at DIA 2013

As a leading regional CRO, Novotech has been actively involved in hundreds of drug development pr

報告
2014/9/30 新聞

Novotech Update: Novotech shares the importance of good clinical trial project management with…

Novotech recently delivered an educational workshop on the importance of ‘Timeline Management and

報告
2014/6/15 新聞

Novotech Update: 8 reasons why Australia should be your next clinical trial destination

Australia is internationally recognised for its superior clinical research and healthcare infrast

報告
2014/5/10 新聞

Novotech announces four country Asia expansion at AusBiotech 2009

October 27, 2009

報告
2014/3/10 新聞

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted by Xtalks

Clinical Trial Planning in Asia: A Roadmap for Biotech Sponsors, Upcoming Webinar Hosted

報告
2013/6/23 新聞

iTnews

Novotech runs clinical trials on Oracle 26th October 2010

報告
2013/5/31 新聞

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in…

Imugene’s clinical review for HER-Vaxx is now complete HER-Vaxx Phase 1b/2 in gast

報告
2013/5/6 新聞

Novotech Update: 8 reasons why China should be your next clinical trial destination

Happy Chinese New Year!

報告
2013/2/4 新聞

Novotech recognised as Asia Pacific growth leader by Frost & Sullivan research analysts

Sydney, Australia: 

報告
2011/7/5 新聞

Novotech wins ‘Australian Exporter of The Year’ at the India Australia Business Community Awards

Novotech has been awarded ‘Australian Exporter of The Year’ the 2017 Indian Australia Business Co

報告
2011/7/5 新聞

NOVOGEN ENGAGES CONTRACT RESEARCH ORGANISATION TO CONDUCT CANTRIXIL PHASE 1 CLINICAL TRIAL

Sydney, November 24, 2015 - US-Australian drug discovery company, Novogen Limited (ASX:NRT: NASDA

報告
2011/6/15 新聞

SureClinical eTMF Cloud Selected by Novotech to automate and accelerate clinical operations…

SureClinical eTMF Cloud Selected by Novotech to automate an

報告
2010/11/3 新聞

Novotech named a finalist in the 2017 Premier’s NSW Export Awards

Novotech has been named as a finalist in the Health and Biotechnology category of the upcoming 20

報告
2010/10/29 新聞

BioSpectrum Asia: Australia - A thriving lifescience hub with a global reach

In an interview with BioSpectrum Asia, Novotech CEO Dr John Moller provides his thoughts on the s

報告
2010/10/27 新聞

Novotech receives CRO Leadership Awards recognition from Life Science Leader

Life Science Leader Magazine featured Novotech in its May edition’s CRO supplement and attributed

報告
2010/10/27 新聞

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Growth

Novotech Selects Oracle’s Siebel Clinical Trial Management System to Support Continued Gr

報告
2010/10/26 新聞

NOVOTECH CRO ANNOUNCES MOU WITH KOREA DRUG DEVELOPMENT FUND (KDDF) AT DIA 2014

San Diego, CA, June 15, 2014 | Novotech, Australia’s largest clinical CRO with o

報告
2010/8/25 新聞

Video Recording: Australia: Preferred Destination for Early Phase Clinical Trials

 The study was supported by Novotech, Australia’s largest independent clinical contract research

報告
2010/8/25 新聞

Novotech leads the fast growing Asia Pacific clinical research sector with another Frost & Sullivan…

Sydney, Australia, February 17, 2015

報告
2010/6/21 新聞

Novotech and Deloitte Launch U.S. Biotech Briefings about 60% Savings for Early Phase Clinical…

Sydney, Australia – October 27, 2016 In an industry first Novotech and Deloitte have teamed up to

報告
2010/6/15 新聞

Novotech Update: Five things you need to know about China’s changing clinical trial environment

Novotech Update: New policy reforms in China focus on reducing clinical trial start up ti

報告
2010/6/4 新聞

Australian clinical research company expands operation in Hong Kong

Sydney-based Novotech today (January 15) announced that it has expanded its Hong Kong operation i

報告
2010/6/2 新聞

Herpes Zoster Novel Treatment Hope From Tasmanian Abalone Gets $1.2 Million Boost

The team aims to commercialize a novel treatment for Herpes simplex and Herpes zoster utilizing a

報告
2010/6/2 新聞

Experienced Australian CRO attains Medidata accreditation to offer enhanced clinical trial services

Media contact: Susan Fitzpatrick-Napier DMG

報告
2010/6/2 新聞

Medidata Solutions Welcomes First Australian CRO to ASPire to Win Channel Partner Program

– Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development

報告
2010/4/19 新聞

Novotech 被美商弗若斯特和沙利文 (Frost & Sullivan) 公司的研究分析師評選為亞太地區最佳成長領導公司

美商弗若斯特和沙利文 (Frost & Sullivan) 公司的亞太區醫療保健實務行業經理 Sanjeev Kumar 在表揚 Novotech 獲得這最具聲望的獎項時說：「Novot

報告
2010/4/15 新聞

Novotech Update: Taiwan simplifies its First In Human regulatory process, reducing timelines by up…

The Taiwanese Ministry for Health and Welfare Food and Drug Administration (TFDA) recently announ

報告
2009/10/27 新聞

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning at the…

Novotech CEO to speak on Clinical Projects – Faster and Smarter it’s All in the Planning

報告
2009/8/31 新聞

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION

NOVOTECH CRO ATTRACTS INVESTMENT FOR ASIA CLINICAL TRIAL EXPANSION

報告